How can we monitor improvements in early diagnosis?
This post was created by Amy Tickle, a Cancer Research UK-funded PhD student in the Cancer Prevention Group. Amy is currently in her second year […]
quality assurance
Beyond trust: collective understanding of the common good and patient data
This post was written by Dr Jessica Barnes, psychologist/behavioural scientist and qualitative researcher in the Cancer Behavioural Science Group at King’s College London. She is […]
Medical research and the double-edged sword of data protection
Just over two years ago, on the 25th of May 2018, the UK government implemented the Data Protection Act across the country. This was the latest […]
Medical research and the common law of confidentiality
In this series, members of our group, the wider research field & individuals from public interest groups will debate the use of patient data in […]
Does the quality and type of screening test matter when determining safe intervals between cervical screening tests?
The question of “how often should women go for cervical screening?” has long been controversial. In the past, many countries recommended screening annually whereas in […]
Data protection versus health protection
On 25th of May 2018 the EU General Data Protection Regulation (GDPR) went live. GDPR is designed to protect EU citizens from organisations using their data […]
To tell or not to tell – what should we do?
The clinical director of the Irish national cervical screening programme Ireland, Dr Grainne Flannelly, resigned at the end of April. It was revealed that she […]
Is it safe to export cancer screening?
A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her […]